CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

Earnings came in at $2.25 a share on revenue of $94.6 billion in the quarter, way above analysts' expectations.

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

This was the stock's third consecutive day of losses.

She most recently served as chief physician executive of healthcare performance improvement ... of news investors really like to hear. Is CVS Health stock a buy? After today's rebound, CVS Health ...

Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.

CVS reported $97.7 billion in revenue and adjusted EPS of $1.19, above the estimates, driven by strong performance ... expects limited stock buying in the managed care and healthcare facilities ...

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my analysis on CVS stock's earnings here.

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In this article, we are going to take a look at where CVS Health Corporation (NYSE ... We sifted through stock screeners, financial media reports, and ETFs to compile a list of 25 telehealth ...

She most recently served as chief physician executive of healthcare performance improvement ... After today's rebound, CVS Health stock is up more than 50% year to date. Is the stock a buy?